人工智能在糖尿病个性化治疗中的伦理挑战与治理策略

The Ethical Challenge and Governance Strategies of Artificial Intelligence in Personalized Diabetes Treatment

人工智能赋能糖尿病个性化治疗为缓解我国医疗资源紧张、提升糖尿病诊疗效率、实现全周期的远程化管理提供了更好的解决思路。现阶段,糖尿病自我管理系统、糖尿病及并发症智能预测和早筛系统、人工胰腺闭环系统的发展显著提高了治疗精准度和效率,优化了患者自我管理能力,推动了医疗实践的革新。同时,人工智能在该领域的发展也引发了如数据隐私与安全、算法偏见与公平性、知情同意与数据使用透明度、诊疗决策与责任鸿沟等一系列伦理挑战。最后,提出可行的治理策略,旨在关注技术与伦理标准的协调性,实现人工智能在糖尿病个性化治疗中的可持续发展。

The application of artificial intelligence(AI)in personalized diabetes treatment provides a better solution to ease the tension of medical resources in China,improve the efficiency of diagnosis and treatment of diabetes,and enable comprehensive remote management.Currently,developments of diabetes self-management system,diabetes and complications intelligent prediction and early screening system,and artificial pancreas closed-loop system have significantly improved the accuracy and efficiency of treatment,optimized patients'self-management ability,and promoted the innovation of medical practice.However,the development of AI in this field has also caused a range of ethical challenges,such as data privacy and security,algorithmic bias and fairness,informed consent and data usage transparency,and the responsibility gap in medical decision-making.This paper attempts to propose feasible governance strategies aimed at harmonizing technical and ethical standards to achieve the sustainable development of AI in personalized diabetes treatment.